MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib Markets InsiderFull coverage http://markets.businessinsider.com/news/stocks/MEI-Pharma-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-CDK-Inhibitor-Voruciclib-1012665778
Pharma giant Pfizer pulls out of research into Alzheimer’s BBC NewsFull coverage http://www.bbc.co.uk/news/health-42633871
US FDA accepts Ionis Pharma’s Inotersen NDA for priority review pharmabiz.comFull coverage http://www.pharmabiz.com/NewsDetails.aspx?aid=106609&sid=2
Amplyx Pharmaceuticals Announces Appointment of CFO and Presentation at the JP Morgan 36th Annual Healthcare … Markets InsiderFull coverage http://markets.businessinsider.com/news/stocks/Amplyx-Pharmaceuticals-Announces-Appointment-of-CFO-and-Presentation-at-the-J-P-Morgan-36th-Annual-Healthcare-Conference-1012663034
BRIEF-Beigene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific … ReutersFull coverage https://uk.reuters.com/article/brief-beigene-and-mirati-therapeutics-an/brief-beigene-and-mirati-therapeutics-announce-exclusive-license-agreement-for-sitravatinib-in-the-asia-pacific-region-idUKFWN1P30HN
Neurocrine Biosciences Announces Retirement of Christopher O’Brien, MD, and Appointment of Eiry W. Roberts, MD … Markets InsiderCan A Similar Series of Events Expected At Neurocrine Biosciences, Inc. (NBIX), Dean Foods Company (DF) Post AnalystAs Neurocrine Biosciences INC (NBIX) Stock Value Rose, Shareholder Healthcor Management LP Cut Holding by … BZ WeeklyFull coverage http://markets.businessinsider.com/news/stocks/Neurocrine-Biosciences-Announces-Retirement-of-Christopher-O-Brien-M-D-and-Appointment-of-Eiry-W-Roberts-M-D-as-Chief-Medical-Officer-1012626025
Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary … PR Newswire (press release)Full coverage https://www.prnewswire.com/news-releases/avelas-biosciences-completes-period-1-patient-enrollment-in-phase-2-study-of-avb-620-in-women-with-primary-nonrecurrent-breast-cancer-undergoing-surgery-300577505.html
BRIEF-Pfenex Names Susan A. Knudson As Chief Financial Officer ReutersFull coverage https://www.reuters.com/article/brief-pfenex-names-susan-a-knudson-as-ch/brief-pfenex-names-susan-a-knudson-as-chief-financial-officer-idUSASB0BZQX
Avelas Biosciences Broadens Management Team with Key Executive Additions NB HerardFull coverage https://nbherard.com/business/avelas-biosciences-broadens-management-team-with-key-executive-additions/48119
Clinical Research 